AGP Picks
View all

Niue Health Report
Provided by AGP

Niue Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Niue Health Report.

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

Press releases published on June 3, 2026

iHerb's 618 Big Benefits: Rewarding Users in Hong Kong and Southeast Asia
16 hours ago

iHerb's 618 Big Benefits: Rewarding Users in Hong Kong and Southeast Asia

Indeterminate GlobeNewswire
iHerb618重磅福利回饋香港及東南亞用戶
16 hours ago

iHerb618重磅福利回饋香港及東南亞用戶

Indeterminate GlobeNewswire
Chiesi Global Rare Diseases to Launch the Second Edition of Find For Rare at 2026 ERA Congress to Advance Research in Lysosomal Storage Disorders
17 hours ago

Chiesi Global Rare Diseases to Launch the Second Edition of Find For Rare at 2026 ERA Congress to Advance Research in Lysosomal Storage Disorders

Indeterminate GlobeNewswire
Nicox: Notice of the Ordinary and Extraordinary Shareholders’ Meeting on June 24, 2026 and appointment of an ad hoc representative
18 hours ago

Nicox: Notice of the Ordinary and Extraordinary Shareholders’ Meeting on June 24, 2026 and appointment of an ad hoc representative

Indeterminate GlobeNewswire
Nicox : Convocation à l’Assemblée Générale Ordinaire et Extraordinaire le 24 juin 2026 et désignation d’un mandataire ad hoc
18 hours ago

Nicox : Convocation à l’Assemblée Générale Ordinaire et Extraordinaire le 24 juin 2026 et désignation d’un mandataire ad hoc

Indeterminate GlobeNewswire
JJP Biologics Announces Positive Interim Phase 1b Data for Nebaprubart (JJP-1212), an Anti-CD89 Antagonist, in Linear IgA Disease (LAD)
18 hours ago

JJP Biologics Announces Positive Interim Phase 1b Data for Nebaprubart (JJP-1212), an Anti-CD89 Antagonist, in Linear IgA Disease (LAD)

Indeterminate GlobeNewswire
argenx Presents New Efgartigimod Data Showing Long-Term Sustained Patient Benefit in Myositis and Sjogren’s Disease at EULAR 2026
18 hours ago

argenx Presents New Efgartigimod Data Showing Long-Term Sustained Patient Benefit in Myositis and Sjogren’s Disease at EULAR 2026

Indeterminate GlobeNewswire
Inteleos and Medvarsity Partner to Expand Global POCUS Education Access
Jun. 3, 2026

Inteleos and Medvarsity Partner to Expand Global POCUS Education Access

Indeterminate GlobeNewswire
شراكة Inteleos و Medvarsity لتوسيع التوافر العالمي لتعليم التصوير بأجهزة الموجات فوق الصوتية المتنقلة لدى المريض (POCUS)
Jun. 3, 2026

شراكة Inteleos و Medvarsity لتوسيع التوافر العالمي لتعليم التصوير بأجهزة الموجات فوق الصوتية المتنقلة لدى المريض (POCUS)

Indeterminate GlobeNewswire
ASCO 2026 | Updated Data from an Oral Presentation of InnoCare's Novel BCL2 Inhibitor Mesutoclax in MDS and AML Released
Jun. 3, 2026

ASCO 2026 | Updated Data from an Oral Presentation of InnoCare's Novel BCL2 Inhibitor Mesutoclax in MDS and AML Released

Indeterminate GlobeNewswire

Share this page:

Sign up for:

Niue Health Report

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.